64 results
8-K
EX-1.1
IMVT
Immunovant Inc
15 May 19
Entry into a Material Definitive Agreement
3:50pm
than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier … , customer or supplier of the Company or any Company Affiliate, on the other hand, which is required by the Act, the Exchange Act or the Regulations
8-K
EX-10.9
IMVT
Immunovant Inc
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
or analysis, marketing plans, regulatory information, business plans, personnel data, customer or prospects lists, existing or anticipated agreements … , specifications, rights, devices, drawings, instructions, expertise, trade practices, customer lists, computer data, software (whether in source code
8-K
EX-10.8
w521l
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
8-K
EX-10.6
b9q tbm00n6airb1al2
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
8-K
EX-10.11
bv8500045tcsrpk
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
8-K
EX-10.13
qptn3mmgs465g8d9hin
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
8-K
EX-10.12
sdc9z5kl ufly
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
8-K
EX-10.15
afx2 byah
20 Dec 19
Immunovant Sciences Ltd. Closes Transaction with Health Sciences
5:19pm
8-K
EX-10.1
s1gjd395
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am